期刊文献+

上海市2005—2017年艾滋病抗病毒治疗患者生存情况分析 被引量:9

Survival analysis of HIV/AIDS patients with highly active antiretroviral therapy in Shanghai, 2005-2017
原文传递
导出
摘要 目的了解上海市接受抗病毒治疗的艾滋病病毒感染者和病人生存情况及其影响因素,评估上海市艾滋病抗病毒治疗效果。方法采用回顾性队列方法,收集上海市2005—2017年开始抗病毒治疗的艾滋病病毒感染者和病人的随访信息,随访截止时间为2018年12月31日,用寿命表法计算治疗对象的生存率,用Cox比例风险模型进行生存分析。结果9251例纳入队列的治疗对象平均年龄(38.2±13.2)岁,以男性(8447例,91.3%)和同性性传播(5536例,59.8%)为主。生存时间中位数为21.9个月,因艾滋病死亡194人,治疗1、3、5、10年的累计生存率分别为0.983、0.979、0.972、0.963。多因素Cox分析发现,年龄、基线CD4+T细胞计数、初始治疗方案、是否更换治疗方案、传播途径是治疗对象生存时间的影响因素(P<0.05)。结论上海市艾滋病抗病毒治疗效果显著,应在扩大治疗覆盖面的基础上,尽早开始抗病毒治疗,及时进行必要的治疗方案调整,改善生存质量。 Objective To investigate the survival status of people living with HIV/AIDS(PLHIV)receiving antiretroviral therapy(ART)and its influencing factors in Shanghai,and to evaluate the effect of ART.Methods A retrospective cohort study was used to analyze the follow-up data about PLHIV receiving ART in Shanghai from 2005 to 2017.The follow-up was completed on December 31,2018.Life table method was used to calculate the survival rate of PLHIV with ART,and Cox proportional hazards regression model was employed to explore associated factors of survival time.Results The average age of 9,251 PLHIV enrolled in this study was(38.2±13.2)years,and most were males(8,447 cases,91.3%)and homosexual transmission(5,536 cases,59.8%).The median survival time was 21.9 months.Deaths due to AIDS added up to 194.The accumulated survival rates of 1-,3-,5-and 10-year after initiating ART were 0.983,0.979,0.972 and 0.963,respectively.According to Cox proportional hazards regression analysis results,the factors affecting the survival time of PLHIV receiving ART were age,baseline CD4~+T-cell count,initial ART regimen,adjustment of the regimen and transmission route(all P<0.05).Conclusions The effect of ART in PLHIV in Shanghai is remarkable.ART coverage should be extended,and early ART initiation should be applied to PLHIV.Supervision of ART effect and timely adjustment of the regimen are crucial to improving survival quality of PLHIV.
作者 傅洁 岳清 庄鸣华 郑轶玲 尹鹤峰 宁镇 FU Jie;YUE Qing;ZHUANG Ming-hua;ZHENG Yi-ling;YIN He-feng;NING Zhen(Shanghai Municipal Center for Disease Control and Prevention,Shanghai 200336,China;Shanghai Pulmonary Hospital,Shanghai 200433,China)
出处 《实用预防医学》 CAS 2020年第11期1345-1348,共4页 Practical Preventive Medicine
关键词 艾滋病 抗病毒治疗 生存分析 影响因素 AIDS antiretroviral therapy survival analysis influencing factor
  • 相关文献

参考文献9

二级参考文献71

  • 1张福杰,文毅,于兰,马烨,潘捷,赵燕.艾滋病的抗病毒治疗与我国的免费治疗现状[J].科技导报,2005,23(7):24-29. 被引量:105
  • 2Jennifer PAN.Current progress of China’s free ART program[J].Cell Research,2005,15(11):877-882. 被引量:40
  • 3王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:631
  • 4姚璇,詹发先,彭国平.湖北省艾滋病抗病毒治疗终止原因分析[J].中国艾滋病性病,2006,12(6):495-497. 被引量:27
  • 5VILLASIS - KWWCWE A, RANGEL - FRAUSTO M S, RUIZ - PALACIOS G, et al. Clinical manifestations and survival trends during the first 12 years of the AIDS epidemic in Mexico[J]. Arch Med Res,2001 (32) :162 - 165. 被引量:1
  • 6FONSECA L A,REINGOLD A L,CASSEB J R,et al. AIDS incidence and survival in a hospital - based cohort of asymptomatic HIV seropositive patients in Sao Paulo, Brazil [ J ]. Int J Epidemiol,199q,28(6) :1156 - 1160. 被引量:1
  • 7SUZANNE W. Managing side effects and promoting adherence in patients with HIV disease: The nurse' s role [ EB/OL]. [2005 - 09 - 29 ]. http ://www. medscape. com/viewprogram/4573 被引量:1
  • 8中国疾病预防控制中心性病艾滋病预防控制中心.国家免费艾滋病抗病毒治疗药物手册[M].北京:人民卫生出版社,2007. 被引量:2
  • 9兰青,韦嘉.人类免疫缺陷病毒/艾滋病合并乙型肝炎病毒感染的研究[D].昆明市:昆明医学院,2011. 被引量:1
  • 10Zhang F, Dou Z, Ma Y, et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program [ J ]. Ann Intern Med, 2009,151 (4) :241-251. 被引量:1

共引文献204

同被引文献81

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部